| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/14/1994 | WO1994007474A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 04/14/1994 | WO1994007366A1 Pp14-based therapy |
| 04/14/1994 | WO1994003814A3 Method and kit for pyridinium crosslink assay |
| 04/14/1994 | CA2146544A1 Ptp 1d: a novel protein tyrosine phosphatase |
| 04/14/1994 | CA2145769A1 Trophic factor having ion channel-inducing activity in neuronal cells |
| 04/14/1994 | CA2145762A1 Pp14-based therapy |
| 04/14/1994 | CA2145757A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/14/1994 | CA2145657A1 A .beta.1-6 n-acetylglucosaminyltransferase and encoding dna |
| 04/14/1994 | CA2145517A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia - tissue factor complex |
| 04/14/1994 | CA2124595A1 Process for detecting p53-specific antibodies |
| 04/13/1994 | EP0592358A2 Process for the production of protease inhibitors |
| 04/13/1994 | EP0592230A1 Human monoclonal anti-peptide anti-body and DNA encoding thereof |
| 04/13/1994 | EP0592127A1 Immunoassay for isothiazolones |
| 04/13/1994 | EP0592106A1 Resurfacing of rodent antibodies |
| 04/13/1994 | EP0592035A2 Thermostable DNA polymerase composition comprising a temperature sensitive polymerase inhibitor, diagnostic test kits and methods of use |
| 04/13/1994 | EP0592026A1 Method for determining antigenic reactivity in urine |
| 04/13/1994 | EP0591914A2 Retrovirus of the HIV-group and its application |
| 04/13/1994 | EP0591789A2 Protein forming a water channel and gene therefor |
| 04/13/1994 | EP0591697A2 Cloning and characterization of the growth hormone releasing hormone receptor |
| 04/13/1994 | EP0591605A2 Method for suppressing coloring of human serum albumin |
| 04/13/1994 | EP0591548A1 ANTI-HBs ANTIBODY GENE AND EXPRESSION PLASMID THEREOF |
| 04/13/1994 | EP0591524A1 Process for producing peptide or protein |
| 04/13/1994 | EP0591431A1 Hepatitis c virus (hcv) polypeptides |
| 04/13/1994 | EP0591420A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 04/13/1994 | EP0591369A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 04/13/1994 | EP0591320A1 Suppressor t-cell hybridoma |
| 04/13/1994 | EP0538300B1 O-glycosylated ifn-alpha |
| 04/13/1994 | EP0420936B1 Purified ubiquitin hydrolase, dna sequences encoding same, and its use in recovering polypeptides |
| 04/13/1994 | EP0406395B1 Process for testing for pathogenic listeria bacteria |
| 04/13/1994 | EP0264434B1 Detection of a unique chlamydia strain associated with acute respiratory disease |
| 04/13/1994 | CN1085253A Dictyostelium dipeptidylaminopeptidase |
| 04/12/1994 | US5302702 Chimeric fibroblast growth factors |
| 04/12/1994 | US5302701 Cell growth promoting activity |
| 04/12/1994 | US5302697 For controlling secretion of proteins or peptides by genetically engineered saccharomyces culture products |
| 04/12/1994 | US5302582 Enkastins: new glycopeptides which act to inhibit enkephlinase, processes for their preparation, and their use as pharmaceutical products |
| 04/12/1994 | US5302516 Catalytic and reactive polypeptides and methods for their preparation and use |
| 04/12/1994 | US5302387 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 04/12/1994 | US5302384 Administering to treat inflammation |
| 04/12/1994 | CA1328419C Receptors for efficient determination of ligands and their antagonists or agonists |
| 04/08/1994 | CA2107761A1 Human monoclonal anti-peptide antibody and dna encoding thereof |
| 04/07/1994 | CA2079983A1 Isolated mink growth hormone genes, novel recombinant dna and methods for producing mink growth hormone |
| 04/06/1994 | EP0590747A2 A novel-beta1- 6 N-acetylglucosaminyltransferase, its acceptor molecule, leukosialin, and a method for cloning proteins having enzymatic activity |
| 04/06/1994 | EP0590707A1 Transformation of Phaffia Rhodozyma |
| 04/06/1994 | EP0590689A2 Method for obtaining DNA, RNA, peptides, polypeptides or proteins by means of a DNA-recombinant technique |
| 04/06/1994 | EP0590530A2 Fusion proteins for prodrug-activation |
| 04/06/1994 | EP0590341A2 Module for the culture and the use of the metabolic activity or the obtention of microorganisms |
| 04/06/1994 | EP0590309A2 Bone-related sulfatase-like protein and process for its production |
| 04/06/1994 | EP0590301A2 Method for protecting plants from disease and infestation by gene insertion, and vectors and plant cells containing said genes |
| 04/06/1994 | EP0590138A1 Oral treatment of helicobacter infection |
| 04/06/1994 | EP0590126A1 Polypeptides having kinase activity, their preparation and use |
| 04/06/1994 | EP0590071A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-$g(b)1 BINDING MOLECULES AND USES THEREOF |
| 04/06/1994 | EP0590067A1 Microbially-produced antibody fragments and their conjugates |
| 04/06/1994 | EP0590059A1 Production and recovery of recombinant neurotrophins |
| 04/06/1994 | EP0590058A1 Method for making humanized antibodies |
| 04/06/1994 | EP0590051A1 Intercellular adhesion molecule-3 and its binding ligands |
| 04/06/1994 | EP0589993A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 04/06/1994 | EP0589982A1 Monoclonal antibodies against human tnf-binding protein i (tnf-bp i) |
| 04/06/1994 | EP0589961A1 Assay systems for neurotrophin activity |
| 04/06/1994 | EP0589943A1 Mycobacterium proteins and applications |
| 04/06/1994 | EP0589930A1 GABA-A RECEPTOR SUBUNITS ($g(a)-2, $g(a)-3, $g(a)-5, $g(a)-6, $g(b)-2) AND TRANSFECTED CELLS EXPRESSING THEM |
| 04/06/1994 | EP0589915A1 Production of monoclonal antibodies |
| 04/06/1994 | EP0589894A1 Insecticidally effective peptides |
| 04/06/1994 | EP0512011B1 Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process |
| 04/06/1994 | EP0489116B1 Fusion proteins comprising gm-csf and il-3 |
| 04/06/1994 | EP0432256B1 Improved biological insect control agents and methods of use |
| 04/06/1994 | EP0371026B1 Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils |
| 04/06/1994 | EP0310619B1 Light inducible promoter |
| 04/06/1994 | EP0295285B1 Method for the production of bovine growth hormone using a synthetic gene |
| 04/06/1994 | EP0229126B1 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for purification, removal, inhibition or assay of the inhibitors |
| 04/06/1994 | CN1084891A Sensory nerve antibody and preparing process |
| 04/06/1994 | CN1084890A Edible heme preparing from animal blood by pepsin or animal stomach mucosa hydrolysis |
| 04/06/1994 | CN1084888A Enzymatically-produced dimeric IL-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 04/06/1994 | CN1084855A PFEMP3 malaria antigen, analogs, antibodies and uses thereof |
| 04/05/1994 | US5300631 Antibodies specific for either ras photo-oncogene encoded P21 proteins or ras oncogene encoded P21 proteins but not for both and method of producing same |
| 04/05/1994 | US5300629 Bactericidal and/or bacteriostatic peptides isolated from hemolymph of honeybees |
| 04/05/1994 | US5300434 Determing collagen degradation in vivo |
| 04/02/1994 | CA2107279A1 Dictyostelium dipeptidylaminopeptidase |
| 03/31/1994 | WO1994006929A1 Small cell lung carcinoma specific antibody and antigen |
| 03/31/1994 | WO1994006928A1 Coupled replication-translation methods and kits for protein synthesis |
| 03/31/1994 | WO1994006918A2 Transformation of phaffia rhodozyma |
| 03/31/1994 | WO1994006913A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 03/31/1994 | WO1994006912A1 Epstein-barr virus peptides and antibodies against these peptides |
| 03/31/1994 | WO1994006909A2 A method of preventing tumor metastasis |
| 03/31/1994 | WO1994006904A1 Novel infectious bursal disease virus |
| 03/31/1994 | WO1994006822A1 Method of isolating biomolecules by ion exchange |
| 03/31/1994 | WO1994006814A1 Ikaros: a t cell pathway regulatory gene |
| 03/31/1994 | WO1994006476A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 03/31/1994 | WO1994006475A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/31/1994 | WO1994006471A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 03/31/1994 | WO1994006470A1 Immunoreactive peptides from epstein-barr virus |
| 03/31/1994 | WO1994006463A1 Immortalized cells and uses therefor |
| 03/31/1994 | WO1994006454A2 Inhibitiion of retrovirus infection |
| 03/31/1994 | WO1994006449A2 Morphogen-induced liver regeneration |
| 03/31/1994 | WO1994006448A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/31/1994 | WO1994006446A1 Hepatitis a virus vaccines |
| 03/31/1994 | WO1994004691A3 Dimer and multimer forms of single chain polypeptides |
| 03/31/1994 | WO1994003611A3 Ptp-d subfamily of protein tyrosine phosphatases |
| 03/31/1994 | WO1994003610A3 Isolation and cloning of a protein with tyrosine-phosphatase activity |
| 03/31/1994 | WO1994003602A3 A novel human dopamine receptor and its uses |
| 03/31/1994 | WO1994001548A3 Human nucleic acid fragments, isolated from brain adrenal tissue, placenta or bone narrow |